- Home
- VRSN vs ZBH Comparison
VRSN vs ZBH Comparison
Compare VRSN & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRSN | ZBH |
|---|---|---|
| Founded | 1995 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 19.5B |
| IPO Year | 1997 | 2001 |
Fundamental Metrics
Financial Performance| Metric | VRSN | ZBH |
|---|---|---|
| Price | $271.99 | $79.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 20 |
| Target Price | ★ $317.67 | $104.56 |
| AVG Volume (30 Days) | 868.6K | ★ 2.1M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.20% | 1.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.24 | 3.55 |
| Revenue | $1,656,600,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $6.78 | $4.96 |
| Revenue Next Year | $5.37 | $3.76 |
| P/E Ratio | $43.46 | ★ $23.31 |
| Revenue Growth | 6.37 | ★ 7.20 |
| 52 Week Low | $209.34 | $81.35 |
| 52 Week High | $310.60 | $108.29 |
Technical Indicators
Market Signals| Indicator | VRSN | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 60.80 | 24.74 |
| Support Level | $261.99 | N/A |
| Resistance Level | $276.65 | $96.94 |
| Average True Range (ATR) | 8.37 | 2.78 |
| MACD | -1.23 | -1.33 |
| Stochastic Oscillator | 74.07 | 1.05 |
Price Performance
Historical ComparisonAbout VRSN VeriSign Inc.
Verisign is an operator of critical infrastructure within the domain name system, or DNS. As the registry for some of the world's most popular TLDs, .com and .net, Verisign directs DNS resolvers to the appropriate registry where IP addresses are stored. Verisign's control over its TLDs is regulated by ICANN and the NTIA and are subject to contract renewal every six years. The company generates revenue through annual subscriptions allowing customers to use .com and .net as their TLD of choice for their respective websites.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.